Gravar-mail: EFFECTS OF A NOVEL ORALLY ADMINISTERED CALPAIN INHIBITOR SNJ-1945 ON IMMUNOMODULATION AND NEURODEGENERATION IN A MURINE MODEL OF MULTIPLE SCLEROSIS